InnoCare Pharma Limited (OTCMKTS:INCPF) Short Interest Up 129.3% in September

InnoCare Pharma Limited (OTCMKTS:INCPF) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 1,293,000 shares, a growth of 129.3% from the August 31st total of 564,000 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

InnoCare Pharma Stock Performance

Shares of INCPF opened at $3.26 on Monday. InnoCare Pharma has a 52 week low of $3.26 and a 52 week high of $3.72. The firm’s 50-day simple moving average is $3.26 and its 200 day simple moving average is $3.26.

InnoCare Pharma Company Profile

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder.